Indian Journal of Medical Biochemistry

Register      Login

VOLUME 21 , ISSUE 2 ( July-December, 2017 ) > List of Articles


Comparative Study of Potential Diagnostic Biomarkers in Myocardial Infarction with Survival and Myocardial Infarction without Survival

Sangita M Patil, Mangesh Bankar, Ramchandra Padalkar, Abhijit Phatak

Citation Information : Patil SM, Bankar M, Padalkar R, Phatak A. Comparative Study of Potential Diagnostic Biomarkers in Myocardial Infarction with Survival and Myocardial Infarction without Survival. Indian J Med Biochem 2017; 21 (2):106-111.

DOI: 10.5005/jp-journals-10054-0031

License: CC BY 3.0

Published Online: 01-12-2013

Copyright Statement:  Copyright © 2017; The Author(s).



Because of the varied presentation and associated high mortality, the identification of patients with acute myocardial infarction (MI) is very critical for patient management and has a bearing on the prognosis. The goal of present study was to correlate the diagnostic value of cardiac biomarkers in MI with survival and MI without survival.

Materials and methods

Diagnostic case—control study was conducted on 110 MI patients presenting to the Emergency Department within 12 hours of acute chest pain, and 120 healthy age- and sex-matched volunteers formed the control group. Serum ischemia-modified albumin (IMA), troponin I (TnI), creatine kinase-MB (CK-MB), lactate dehydrogenase (LDH), and aspartate transaminase (AST) were measured. Statistical software SYSTAT version 12 was used to analyze the data. The results were expressed in mean ± standard deviation. Comparisons of study groups and study groups with control groups were done by applying Z test. Correlation was tested by Student's t-test at 5% (p = 0.05) and 1% (p = 0.01) level of significance.


Mean levels of serum IMA, TnI, CK-MB, LDH, and AST levels were significantly higher (p < 0.01) in patients with MI as compared with healthy controls. Serum levels of cardiac biomarkers were significantly elevated (p < 0.01) in MI patients without survival as compared with MI with survival.


The serum levels of biomarkers were increased in MI without survival as compared with MI with survival. These study data prove that these changes might be helpful to obtain a comprehensive view of the infarct size and severity of vascular stenotic lesions.

How to cite this article

Patil SM, Bankar M, Padalkar R, Phatak A. Comparative Study of Potential Diagnostic Biomarkers in Myocardial Infarction with Survival and Myocardial Infarction without Survival. Indian J Med Biochem 2017;21(2):106-111.

  1. Textbook of pathology. Foreword by Ivan Danjanov. 5th ed. Tunbridge Wells: Anshan Publishers; 2005. pp. 305-326.
  2. Erythrocyte adenosine deaminase in post myocardial infarction angina patients. Indian J Clin Biochem 2009 Jan;24(1):49-51.
  3. Socioeconomic status and the prevalence of coronary heart disease risk factors. Asia Pac J Clin Nutr 2002 Jun;11(2):98-103.
  4. Disease and injury, regional estimates, cause specific estimates for 2008. Geneva: World Health Orgnization; 2011.
  5. Estimation of contribution of changes in coronary care to improving survival, event rates and coronary heart disease mortality across the WHO MONICA project population. Lancet 2000 Feb;335(9205):688-700.
  6. Changes in plasma fibrinogen, homocysteine and lipid profile in coronary artery disease patients of north Indian (Punjab) population. Biomed Res 2008 May;19(2):125-128.
  7. Biomarkers in acute myocardial infarction. BMC Med 2010 Jun;8:34.
  8. Analysis of serum cardiac biomarkers and treadmill exercise test electrocardiogram for the diagnosis of coronary heart disease in suspected patients. Acta Biochem Biophys Sin (Shanghai) 2010 Jan;42(1):39-44.
  9. Biomarkers for the evaluation of patients with ischemic heart disease. Biomarkers in heart disease. 1st ed. Malden (MA): Blackwell Publishing; 2008. pp. 3-19.
  10. Ischemia modified albumin measured with ultra-filtration assay in early diagnosis of acute coronary syndrome. World J Emerg Med 2010;1(1):37-40.
  11. Early diagnosis of acute coronary syndrome with sensitive troponin I and ischemia modified albumin. Iranian Cardiovascular Research Journal 2010;4(4):144-151.
  12. IFCC methods for the measurement of catalytic concentration of enzymes. JIFCC 1989;1:130.
  13. Evaluation of two modified cardiac troponin I enzyme immunoassays. Clin Chem Lab Med 2002 Aug;40(8):837-992.
  14. A novel assay for cobalt-albumin binding and its potential as a marker for myocardial ischemia-a preliminary report. J Emerg Med 2000 Nov;19(4):311-315.
  15. ; Henderson, AK. Clinical enzymology. In:Burtis CA, Ashwood ER, editors. Tietz textbook clinical chemistry. 3rd ed. Philadelphia (PA): W B Sauders; 1994. pp. 617-721.
  16. In effect of preanalytical variables on clinical laboratory tests. 2nd ed. Washington: AACC Press; 1997. p. 499.
  17. Oxidative stress and cardiac biomarkers in patients with acute myocardial infarction. Eur J Sci Res 2009 Jan;27(2):275-285.
  18. Serum cardiac markers in patients with acute myocardial infarction: oxidative stress, C-reactive protein and N-terminal probrain natriuretic peptide. J Clin Biochem Nutr 2007 Jul;41(1):50-57.
  19. Sensitive Troponin I assay in early diagnosis of acute myocardial infarction. N Engl J Med 2009 Aug;361(9):867-877.
  20. Ischemia modified albumin improves the usefulness of standard cardiac biomarkers for the diagnosis of myocardial ischemia in the emergency department setting. Am J Clin Pathol 2005 Jan;123(1):140-145.
  21. Utility of admission cardiac troponin and ischemia modified albumin measurements for rapid evaluation and rule out of suspected acute myocardial infarction in the emergency department. Emerg Med J 2006 Apr;23(4):256-261.
  22. Evidence that the principal Coll-binding site in human serum albumin is not at the N terminus: implication on the albumin cobalt binding test for detecting myocardial ischemia. Biochemistry 2007 Feb;46(8):2267-2274.
  23. Prognostic significance of ischemia modified albumin in acute ischemic stroke patients: a preliminary study. Ann Neurosci 2011 Jan;18(1):5-7.
  24. Correlation between myocardial enzyme serum levels and markers of inflammation with severity of coronary artery disease and genisini score: a hospital based, prospective study in greek patients. Clin Interv Aging 2008 Dec;3(4):699-710.
  25. Comparative study of serum lactic acid, lactate Dehydrogenase and lipid profile in ischemic heart disease patients and healthy control. IBN Al-Haitham J Pure Appl Sci 2010;23(1):171-179.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.